Literature DB >> 12066273

Simultaneous bilateral total hip arthroplasty in sickle cell disease.

I Ilyas1, P Moreau.   

Abstract

Simultaneous bilateral uncemented total hip arthroplasty for avascular necrosis of the femoral head resulting from sickle cell disease was performed in 18 consecutive patients (36 hips). The patients were followed 2 to 10 years (mean, 5.7 years). All patients showed improvement in postoperative hip scores compared with preoperative scores for pain, range of motion, and function. There were 2 immediate postoperative complications related to sickling of red blood cells. One intraoperative fracture of the proximal femur occurred. There was 1 superficial and 1 deep infection. There was no femoral stem loosening, but 1 protrusio acetabuli occurred. One acetabular cup was revised for instability. Heterotopic ossification developed in 2 patients. Simultaneous bilateral total hip arthroplasty in sickle cell disease is a good option in a select group of patients with adequate hydration and ventilation in the perioperative and postoperative periods. Copyright 2002, Elsevier Science (USA).

Entities:  

Mesh:

Year:  2002        PMID: 12066273     DOI: 10.1054/arth.2002.31084

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  12 in total

Review 1.  Current concepts on osteonecrosis of the femoral head.

Authors:  Joaquin Moya-Angeler; Arianna L Gianakos; Jordan C Villa; Amelia Ni; Joseph M Lane
Journal:  World J Orthop       Date:  2015-09-18

2.  Total THA in adult osteonecrosis related to sickle cell disease.

Authors:  Philippe Hernigou; Sebastien Zilber; Paolo Filippini; Gilles Mathieu; Alexandre Poignard; Frederic Galacteros
Journal:  Clin Orthop Relat Res       Date:  2008-01-10       Impact factor: 4.176

Review 3.  Surgical management of osteonecrosis of the femoral head in patients with sickle cell disease.

Authors:  Atul F Kamath; Michael H McGraw; Craig L Israelite
Journal:  World J Orthop       Date:  2015-11-18

4.  Massive septic pelvic osteolysis following revision total hip arthroplasty in a patient with sickle cell anemia: clinical presentation and review of the literature.

Authors:  Panagiotis Korovessis; Thomas Repantis
Journal:  Eur J Orthop Surg Traumatol       Date:  2011-09-27

5.  Treatment for avascular necrosis of bone in people with sickle cell disease.

Authors:  Arturo J Martí-Carvajal; Ivan Solà; Luis H Agreda-Pérez
Journal:  Cochrane Database Syst Rev       Date:  2019-12-05

6.  Efficacy of autologous stem cell-based therapy for osteonecrosis of the femoral head in sickle cell disease: a five-year follow-up study.

Authors:  Gildasio Cerqueira Daltro; Vitor Fortuna; Eliane Silva de Souza; Marcela Miranda Salles; Ana Claudia Carreira; Roberto Meyer; Songeli Menezes Freire; Radovan Borojevic
Journal:  Stem Cell Res Ther       Date:  2015-05-29       Impact factor: 6.832

7.  Management of femoral head osteonecrosis: Current concepts.

Authors:  Sujit Kumar Tripathy; Tarun Goyal; Ramesh Kumar Sen
Journal:  Indian J Orthop       Date:  2015 Jan-Feb       Impact factor: 1.251

8.  Revision hip arthroplasty in sickle cell disease.

Authors:  Aydýner Kalacý; Cenk Ozkan; Emre Toğrul
Journal:  Ann Saudi Med       Date:  2007 Mar-Apr       Impact factor: 1.526

Review 9.  Hypoxia-inducible factor (HIF): how to improve osseointegration in hip arthroplasty secondary to avascular necrosis in sickle cell disease.

Authors:  Akintunde George; Marianne Ellis; Harinderjit Singh Gill
Journal:  EFORT Open Rev       Date:  2019-09-10

10.  Re: The adult hip joint in Saudi Arabia.

Authors:  Mohammed Moussa; Abdulla Alumran
Journal:  Ann Saudi Med       Date:  2007 Mar-Apr       Impact factor: 1.526

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.